Cancer cure in mice to be tested in humans: related news

Cancer Resistance Technique Moves To Human Trials

TaeKwonDood tips us to news that a new cancer resistance treatment is going into clinical trials after being quite successful at eradicating cancer in mice. Researchers discovered that certain white blood cells called granulocytes from cancer-immune mice were able to cure cancer in other mice. Now, doctors are putting out the call for healthy granulocyte donors in order to test how well it works on humans. The article quotes lead researcher Zheng Cui saying, "In mice, we've been able to eradicate even highly aggressive forms of malignancy with extremely large tumors. Hopefully, we will see the same results in humans. Our laboratory studies indicate that this cancer-fighting ability is even stronger in healthy humans."

Cancer 'Cure' In Mice To Be Tested In Humans

Scientists at Wake Forest University Baptist Medical Center are about to embark on a human trial to test whether a new cancer treatment will be as effective at eradicating cancer in humans as it has proven to be in mice.

Cancer 'cure' in mice to be tested in humans

WINSTON-SALEM, N.C. – Scientists at Wake Forest University Baptist Medical Center are about to embark on a human trial to test whether a new cancer treatment will be as effective at eradicating cancer in humans as it has proven to be in mice.

Cancer cure in mice to get human trials: Wake Forest University scientists studying genetic immunity in mice to start testing humans

Jun. 29--Clinical trials begin this week at Wake Forest University on a cancer therapy that has completely cured the disease in every mouse tested over the past few years.

Cancer cure trials move from mice to human

Washington, June 30: A potential cure for cancer that destroyed advanced tumours in mice is to be tested on human patients for the first time by scientists at Wake Forest University Baptist Medical Center.

Vaccine Containing Tumor Antigen Reduces Colon Cancer Spread in Mice Axentis Pharma Gains Patents from BioDevelops Pharma to Further Cystic Fibrosis Program Articles Most Viewed Most Emailed Top Searches Optimizing Utilization of Biomarkers Meth

Scientists at the Kimmel Cancer Center at Jefferson Medical College have found a way to immunize mice against the development of metastatic disease. Their approach is based on the fact that the intestines have a separate immune system from the rest of the body. The researchers were able to show that mice immunized with an intestinal protein developed fewer lung and liver metastases after injection with colon cancer cells than did control animals.

U.S. scientists use PET scans to locate, track prostate cancer cells in mice

WASHINGTON, July 13 (Xinhua) -- Using PET scans, U.S. researchers successfully pinpoint and track prostate cancer cells as they spread to the lymph nodes in mice, a method they believe has the potential to improve the way advanced prostate cancer is treated in men.

Nanotech Revives a Cancer Drug

In the 1990s, a cancer drug called TNP-470 dramatically increased life span for some patients and led to complete cancer regression in others. But when neurotoxicity was detected in some patients, clinical trials were halted. This is a common problem: many drugs that show great promise in the lab fail in clinical trials due to unforeseen toxicity. Nanomedicine, however, promises a way to make safer, more effective versions of such drugs. Researchers at Children's Hospital Boston have created and tested in mice a safer version of TNP-470.

Patent bid sparks cancer-test price fears

A decision by Genetic Technologies could make breast cancer examinations more expensive, according to Cancer Australia. Genetic holds the Australian and New Zealand patent licences for a test that detects mutations in breast cancer genes, and recently announced plans to use its patent rights to conduct all future testing itself. Women with the defective gene have an 85 per cent change of contracting the disease, against a community-wide average of around nine per cent. Cancer Council Australia CEO, Ian Olver, said allowing genes to be patented could be problematic in the long term and could compromise the Human Genome Project

Jefferson researchers show antibody to breast cancer-secreted protein blocks metastasis

(PHILADELPHIA) Scientists at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have made a key discovery about the mechanism of breast cancer metastasis, the process by which cancer spreads. Focusing on a gene dubbed "Dachshund," or DACH1, they are beginning to pinpoint new therapeutic targets to halt the spread of cancer.

Olympic Gold Medalist Inspires Cancer Patients Through Blog

BEIJING, August 18, 2008 /PRNewswire/ -- Dick Fosbury, gold medalist from the 1968 Olympic Games in Mexico City and innovator of the high jump technique dubbed the "Fosbury Flop," which revolutionized the sport and is now considered its standard, was stricken by cancer lymphoma in March. After undergoing surgery, radiation and chemotherapy treatment at the Cancer Center, the State of New Mexico's Official Cancer Center based on the UNM campus in Albuquerque, NM, Fosbury is currently attending the 2008 Olympics Games in Beijing to celebrate the 40th anniversary of the "Fosbury Flop" and inspire cancer patients throughout the world.

Olympic Gold Medalist Inspires Cancer Patients Through Blog

BEIJING, Aug. 18 /PRNewswire/ -- Dick Fosbury, gold medalist from the 1968 Olympic Games in Mexico City and innovator of the high jump technique dubbed the "Fosbury Flop," which revolutionized the sport and is now considered its standard, was stricken by cancer lymphoma in March. After undergoing surgery, radiation and chemotherapy treatment at the University of New Mexico Cancer Center, the State of New Mexico's Official Cancer Center based on the UNM campus in Albuquerque, NM, Fosbury is currently attending the 2008 Olympics Games in Beijing to celebrate the 40th anniversary of the "Fosbury Flop" and inspire cancer patients throughout the world.

Olympic Gold Medalist Inspires Cancer Patients Through Blog

BEIJING, Aug 18, 2008 /PRNewswire via COMTEX/ -- Dick Fosbury, gold medalist from the 1968 Olympic Games in Mexico City and innovator of the high jump technique dubbed the "Fosbury Flop," which revolutionized the sport and is now considered its standard, was stricken by cancer lymphoma in March. After undergoing surgery, radiation and chemotherapy treatment at the University of New Mexico Cancer Center, the State of New Mexico's Official Cancer Center based on the UNM campus in Albuquerque, NM, Fosbury is currently attending the 2008 Olympics Games in Beijing to celebrate the 40th anniversary of the "Fosbury Flop" and inspire cancer patients throughout the world.

LegalView Informs Mesothelioma Blog Readers of A New Clinical Trial Available for Victims of Asbestos-Induced Lung Cancer

blog on an opportunity for pleural mesothelioma cancer victims to participate in a clinical trial being conducted at the Mesothelioma Center at New York-Presbyterian Hospital and Columbia University Medical Center. The clinical trial hopes to improve surgical and radiation treatments for patients of pleural mesothelioma cancer. Currently, the most common treatment for patients of the asbestos-induced cancer is removal of the victim's lung. Individuals who suffer from pleural mesothelioma or any other form of mesothelioma cancer are advised to speak with an experienced

LSU Health Sciences Center Inventor Awarded Patent for New Procedure to Detect Cancer Spread

NEW ORLEANS, June 24 (AScribe Newswire) -- Eugene A. Woltering, MD, FACS, The James D. Rives Professor of Surgery and Chief of the Sections of Surgical Oncology & Endocrine Surgery at LSU Health Sciences Center New Orleans, has been awarded a US Patent for a one-step method to rapidly identify "sentinel nodes;" the lymph nodes most likely to contain early metastasis from a primary cancer. Preliminary research indicates that the procedure which consists of injection of a radiolabeled dye around a cancer can identify sentinel nodes that receive lymphatic drainage from the tumor within 10 minutes. Dr. Woltering's patent is based on linking a radioactive iodine molecule to the blue dye commonly used in these sentinel node procedures. One of the major ways to determining the prognosis of a cancer involves determining whether the cancer has met

LegalView Informs Mesothelioma Blog Readers of A New Clinical Trial Available for Victims of Asbestos-Induced Lung Cancer

(EMAILWIRE.COM, July 08, 2008 ) Denver, CO - LegalView.com, the number one legal resource on the Web, offered information through its mesothelioma information (http://mesothelioma.legalview.com/blog ) blog on an opportunity for pleural mesothelioma cancer victims to participate in a clinical trial being conducted at the Mesothelioma Center at New York-Presbyterian Hospital and Columbia University Medical Center. The clinical trial hopes to improve surgical and radiation treatments for patients of pleural mesothelioma cancer. Currently, the most common treatment for patients of the asbestos-induced cancer is removal of the victim's lung. Individuals who suffer from pleural mesothelioma or any other form of mesothelioma cancer are advised to speak with an experienced mesothelioma lawyer (http://mesothelioma.

New panel of mice helps predict how drugs are broken down in humans

Humans express several proteins that breakdown the synthetic chemicals and drugs (collectively known as xenobiotics) that we ingest or are administered. Expression of these proteins is itself regulated by the xenobiotic-sensing proteins PXR and CAR. Developing animal models to determine the relative importance of PXR and CAR for humans to breakdown a specific drug has been difficult because the human and animal proteins sense different xenobiotics.

Study of dark-skinned mice leads to protein linked to bone marrow failure in humans

The study of dark-skinned mice has led to a surprising finding about a common protein involved in tumor suppression, report researchers at the Stanford University School of Medicine. The results may lead to new treatments for bone marrow failure in humans.

Protein Linked To Bone Marrow Failure In Humans Found Through Study Of Dark-skinned Mice

The study of dark-skinned mice has led to a surprising finding about a common protein involved in tumor suppression, report researchers at the Stanford University School of Medicine. The results may lead to new treatments for bone marrow failure in humans.

Stanford study of dark-skinned mice leads to protein linked to bone marrow failure in humans

STANFORD, Calif. - The study of dark-skinned mice has led to a surprising finding about a common protein involved in tumor suppression, report researchers at the Stanford University School of Medicine. The results may lead to new treatments for bone marrow failure in humans.

New Research On Pre-eclampsia In Mice May Have Important Implications For Humans

In a new March of Dimes-funded study of pre-eclampsia, a serious and potentially deadly disorder that affects about 5 percent of pregnancies, researchers have found results in mice that may have important implications for diagnosis and treatment in humans.

New research on pre-eclampsia in mice may have important implications for humans

In a new March of Dimes-funded study of pre-eclampsia, a serious and potentially deadly disorder that affects about 5 percent of pregnancies, researchers have found results in mice that may have important implications for diagnosis and treatment in humans.

New research on pre-eclampsia in mice may have important implications for humans

WHITE PLAIN, N.Y., JULY 27, 2008 – In a new March of Dimes-funded study of pre-eclampsia, a serious and potentially deadly disorder that affects about 5 percent of pregnancies, researchers have found results in mice that may have important implications for diagnosis and treatment in humans.

Towards an Exercise Pill

aztektum among many other readers sent us news that medical researchers have developed two drugs that can build muscle tone in mice without exercise. While such an advance may inspire dreams of a "couch potato pill," the article mostly talks about other medical uses, should the drugs prove safe and effective in humans. The doctor in charge of the research is working with sports authorities to develop a test to detect the drugs in athletes. "Researchers at the Salk Institute in San Diego reported that they had found two drugs that did wonders for the athletic endurance of couch potato mice. One drug, known as Aicar, increased the mice's endurance on a treadmill by 44 percent after just four weeks of treatment. A second drug, GW1516, supercharged the mice to a 75 percent increase in endurance but had to be combined with exercise to have any

Low-Carb Blog Reader Asking For 'Relay For Life' Cancer Drive Help

Cancer more than any other disease has ripped through families, communities, churches, organizations, and cities all across America like no other disease I know. Just two weeks ago, endometrial cancer took the wife of national radio talk show host Mike Gallagher after months of battling it with chemotherapy and just one year ago my friend and former minister of music Steve Dyar went home to be with the Lord after esophageal cancer overtook his body.

Search took 0.08 seconds.